|
Volumn 178, Issue 1, 2003, Pages 44-
|
Withdrawal of methylphenobarbitone
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIPARKINSON AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
ERGOTAMINE;
ETHOSUXIMIDE;
METHYLPHENOBARBITAL;
NEOSTIGMINE;
PHENOBARBITAL;
PHENYTOIN;
PRIMIDONE;
ANXIETY DISORDER;
AUSTRALIA;
CONSULTATION;
DRUG BLOOD LEVEL;
DRUG MARKETING;
DRUG SAFETY;
DRUG USE;
DRUG WITHDRAWAL;
EPILEPSY;
GENERAL PRACTITIONER;
HUMAN;
LETTER;
PRESCRIPTION;
TABLET;
|
EID: 0037421312
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2003.tb05045.x Document Type: Letter |
Times cited : (3)
|
References (1)
|